."there may be subtle differences (between animals and humans) that we don't know about," klein said. .'indian ip and liabilities law barrier to pharma r&d investment' http://lm360.us/Talamantes-grandpa-of-Yorn-from-Niella-Belbo?Lindenfels=129 .despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . . . . . august 2009 (18) .